Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ceftizoxime MeSH Descriptor Data 2025


MeSH Heading
Ceftizoxime
Tree Number(s)
D02.065.589.099.249.190.190.145
D02.886.665.074.190.190.145
D03.633.100.300.249.190.190.145
Unique ID
D015296
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015296
Scope Note
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Entry Term(s)
Cefizox
Ceftizoxime Monosodium Salt
Ceftizoxime Sodium
FK-749
FK749
FR-13749
SK&F 88373-2
SKF-88373
Pharm Action
Anti-Bacterial Agents
Registry Numbers
C43C467DPE
0
26337D5X88
Related Numbers
26337D5X88
68401-81-0
68401-82-1
CAS Type 1 Name
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-
Previous Indexing
Cefotaxime/analogs & derivatives (1982-1988)
Cephalosporins (1979-1981)
Public MeSH Note
89
History Note
89
Date Established
1989/01/01
Date of Entry
1988/05/24
Revision Date
2017/05/24
Ceftizoxime Preferred
FK749 Narrower
FR-13749 Narrower
SK&F 88373-2 Narrower
SKF-88373 Narrower
Cefizox Narrower
Ceftizoxime Sodium Narrower
page delivered in 0.149s